Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Pediatric Research|January 28, 2006
Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysisMaki Fukami, Tomonobu Hasegawa, Reiko Horikawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Administration of anti-CD3 antibodies modulates the immune response to an infusion of α-glucosidase in miceToya Ohashi, Sayoko Iizuka, Yohta Shimada, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|January 17, 2014
OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retinaSatoshi Katagiri, Tamaki Gekka, Takaaki Hayashi, et al.
The Journal of Surgical Research|May 30, 2006
Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in ratsHiroaki Shiba, Tomoyoshi Okamoto, Yasuro Futagawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Induced pluripotent stem cells derived from mouse models of lysosomal storage disordersXing-Li Meng, Jin-Song Shen, Shiho Kawagoe, et al.
Journal of Neuroscience Research|September 30, 2003
Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouseXing-Li Meng, Jin-Song Shen, Toya Ohashi, et al.
Molecular Genetics and Metabolism|October 9, 2012
Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe diseaseYurika Nishiyama, Yohta Shimada, Takayuki Yokoi, et al.
The Journal of Gene Medicine|February 3, 2005
Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe diseaseJin-Song Shen, Xing-Li Meng, Takashi Yokoo, et al.
Biochemical and Biophysical Research Communications|October 27, 2011
Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutationYohta Shimada, Hikaru Nishida, Yurika Nishiyama, et al.
JIMD Reports|September 27, 2014
Proteasome Inhibitor Bortezomib Enhances the Activity of Multiple Mutant Forms of Lysosomal α-Glucosidase in Pompe DiseaseYohta Shimada, Erica Nishimura, Hiroo Hoshina, et al.
Pageof 14